Parabilis Medicines, Inc. ($PBLS)
Filing Information
| Accession Number | 0001231919-26-000779 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 22, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
244,593
Total Value
$6,919,551.27
P&L
+8.9% (+$616,359.06)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Voting Common Stock | โ | Jul 20, 2026 | Purchase | 98,433 | $27.13 | $2,670,487.29 | 26,383,526 | Indirect | See footnotes | View Details | |
Director | Voting Common Stock | โ | Jul 20, 2026 | Purchase | 32,987 | $27.72 | $914,399.64 | 26,416,513 | Indirect | See footnotes | View Details | |
Director | Voting Common Stock | โ | Jul 21, 2026 | Purchase | 21,696 | $27.96 | $606,620.16 | 26,438,209 | Indirect | See footnotes | View Details | |
Director | Voting Common Stock | โ | Jul 21, 2026 | Purchase | 6,504 | $29.17 | $189,721.68 | 26,444,713 | Indirect | See footnotes | View Details | |
Director | Voting Common Stock | โ | Jul 21, 2026 | Purchase | 37,723 | $30.00 | $1,131,690.00 | 26,482,436 | Indirect | See footnotes | View Details | |
Director | Voting Common Stock | โ | Jul 22, 2026 | Purchase | 47,250 | $29.77 | $1,406,632.50 | 26,529,686 | Indirect | See footnotes | View Details |